Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-12-30 CLARK IAN T Director Grant or award · Stock option (right to buy) +16,000 16,000
2016-12-22 Biller Scott Chief Scientific Officer Gift −7,800 40,470
2016-11-14 Biller Scott Chief Scientific Officer Sale −5,000 $65.00 $325K 6,000
2016-11-14 Biller Scott Chief Scientific Officer Option exercise +6,889 $0.47 $3K 55,159
2016-11-14 Biller Scott Chief Scientific Officer Option exercise +14,091 $9.05 $128K 69,250
2016-11-14 Biller Scott Chief Scientific Officer Option exercise +6,520 $31.64 $206K 75,770
2016-11-14 Biller Scott Chief Scientific Officer Sale −27,500 $65.00 $1.8M 48,270
2016-11-14 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −6,889 5,474
2016-11-14 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −14,091 20,000
2016-11-14 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −6,520 35,286
2016-11-10 Biller Scott Chief Scientific Officer Sale −2,128 $60.00 $128K 11,000
2016-11-09 Biller Scott Chief Scientific Officer Sale −2,872 $60.00 $172K 13,128
2016-11-07 Alenson Carman Principal Accounting Officer Grant or award · Stock option (right to buy) +15,000 15,000
2016-10-27 Cantley Lewis Clayton Jr. Director Sale −627 $48.97 $31K 107,778
2016-10-27 Cantley Lewis Clayton Jr. Director Sale −625 $48.97 $31K 107,818
2016-10-26 Cantley Lewis Clayton Jr. Director Sale −627 $48.91 $31K 108,405
2016-10-26 Cantley Lewis Clayton Jr. Director Sale −625 $48.91 $31K 108,443
2016-10-05 Biller Scott Chief Scientific Officer Sale −5,000 $55.00 $275K 16,000
2016-09-28 Cantley Lewis Clayton Jr. Director Sale −627 $54.00 $34K 109,032
2016-09-28 Cantley Lewis Clayton Jr. Director Sale −625 $54.00 $34K 109,068

Page 79 of 80 · 1,590 trades